IP Library Granted Patent US 7,186,854
Granted Patent B2
US 7,186,854 · App. 10/682,530 · Granted Mar 6, 2007

Process for making bicalutamide and intermediates thereof

Assignee: Synthon IP Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,186,854
App. No.
10/682,530
Granted
Mar 6, 2007
Kind
B2
Abstract

Bicalutamide and/or its intermediates are made by the use of p-fluorobenzenesulfinic acid salt as a reagent.

Claims (45)

1. A process for making bicalutamide, which comprises reacting a compound of formula (2)

wherein Z represents a cation, with a suitable reaction partner to form a bicalutamide of formula (1):

or a non-bicalutamide product and, if said reacting step produces said non-bicalutamide product, then converting said non-bicalutamide product to a bicalutamide of formula (1);

wherein said suitable reaction partner is a compound of the formula (3), formula (3.1) or Formula (3.2):

wherein A represents OR, in which R is a hydrogen, a C 1 –C 6 alkyl, a C 3 –C 6 cycloalkyl, a phenyl, or a benzyl group; or an aniline derivative of the formula:

Y represents a leaving group and X represents hydrogen or X and Y join together to form a 3- to 6-membered heterocyclic ring or X and A join together to form a 5- to 10-membered fused or unfused heterocyclic ring with the proviso that if a ring nitrogen is present, it may be substituted by a 3-trifluoromethyl-4-cyano-phenyl group:

wherein Y is as defined for formula (3);

wherein Y is as defined for formula (3).

2. The process according to claim 1 , wherein Z is a cation selected from the group consisting of alkali metals, magnesium halides, and ammoniums.

3. The process according to claim 2 , wherein Z is a sodium cation.

4. The process according to claim 1 , wherein said reacting step is carried out in a bi-phasic reaction system or in a lower alcohol.

5. A process, which comprises reacting a compound of formula (2)

wherein Z represents a cation; with a compound of formula (3)

wherein A represents OR, in which R is a hydrogen, a C 1 –C 6 alkyl, a C 3 –C 6 cycloalkyl, a phenyl, or a benzyl group; or A represents an aniline derivative of the formula:

Y represents a leaving group and X represents hydrogen or X and Y join together to form a 3- to 6-membered heterocyclic ring or X and A join together to form a 5- to 10-membered fused or unfused heterocyclic ring with the proviso that if a ring nitrogen is present, it may be substituted by a 3-trifluoromethyl-4-cyano-phenyl group; to form a compound of the formula (4):

wherein A and X have the same meaning as in formula (3).

6. The process according to claim 5 , wherein Z is a cation selected from the group consisting of alkali metals, magnesium halide, and ammonium.

7. The process according to claim 5 , wherein Y represents a halogen or a group of the formula —OS(O) 2 —R 2 , wherein R 2 represents a hydroxyl group, a C 1 –C 4 alkyl group, a phenyl group, or an alkyl-substituted phenyl group.

8. The process according to claim 7 , wherein Y represents a group selected from the group consisting of iodine, chlorine, bromine, methanesulfonyloxy, and toluenesulfonyloxy.

9. The process according to claim 5 , wherein Y and X join together to complete an oxiran ring.

10. The process according to claim 5 , wherein A is said aniline derivative and said compound of formula (4) is a bicalutamide of formula (1):

11. The process according to claim 10 , wherein said compound of formula (3) is optically active and said bicalutamide is enriched R-bicalutamide.

12. The process according to claim 10 , wherein said produced bicalutamide is racemic bicalutamide and which further comprises isolating the R-bicalutamide isomer therefrom.

13. The process according to claim 10 , wherein Y represents a group selected from the group consisting of iodine, bromine, chlorine, methanesulfonyloxy, and toluenesulfonyloxy.

14. The process according to claim 13 , wherein Y is bromine or iodine.

15. The process according to claim 10 , wherein Y and X together complete an oxiran ring.

16. The process according to claim 14 , wherein Z is a sodium cation.

17. The process according to claim 15 , wherein Z is a sodium cation.

18. The process according to claim 5 , wherein A is OR.

19. The process according to claim 18 , which further comprises converting said compound of formula (4) to a compound of formula (4.1)

wherein L represents a leaving group for an amidation reaction.

20. The process according to claim 19 , wherein L represents a halogen; a group of the formula OS(O) 2 —R 2 , wherein R 2 represents a hydroxyl group, a C 1 –C 4 alkyl group, a phenyl group, or an alkyl-substituted phenyl group; a mixed anhydride group of formula —O—C(O)—R 3 , wherein R 3 is a C 1 –C 4 alkyl group or a phenyl group, each optionally substituted by one or more halogens; or an activated ester group.

21. The process according to claim 20 , wherein R 3 represents a group selected from the group consisting of trifluoromethyl, tert-butyl, isobutyl and o-dichlorophenyl group.

22. The process according to claim 20 , wherein L represents a halogen or a group of the formula —OS(O) 2 —R 2 , wherein R 2 represents a hydroxyl group, a C 1 –C 4 alkyl group, a phenyl group, or an alkyl-substituted phenyl group.

23. The process according to claim 22 , wherein L represents a group selected from the group consisting of bromine, chlorine, methanesulfonyloxy, and toluenesulfonyloxy.

24. The process according to claim 19 , which further comprises reacting said compound of formula (4.1) with an amine of the formula (11):

to form a bicalutamide of formula (1):

25. The process according to claim 24 , wherein said compound of formula (3) is optically active and said bicalutamide is enriched R-bicalutamide.

26. The process according to claim 24 , wherein said produced bicalutamide is racemic bicalutamide and which further comprises isolating the R-bicalutamide isomer therefrom.

27. The process according to claim 18 , which further comprises reacting said compound of formula (4) with an amine of the formula (11):

to form a bicalutamide of formula (1):

28. The process according to claim 27 , wherein A represents hydrogen.

29. The process according to claim 5 , wherein X and A together complete a ring to form a compound selected from the following formulae 3A–3C:

wherein R 8 represents a hydrogen, an C 1 –C 6 alkyl or a C 3 –C 6 cyclcoalkyl; R 9 represents a C 1 –C 6 halogenated alkyl; and Y is as defined for formula (3).

30. The process according to claim 29 , which further comprises hydrolyzing said compound of formula (4) and forming a bicalutamide of formula (1):

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2006
From: SYNTHON BV
To: SYNTHON IP INC.
Reel/Frame 017506/0975 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2003
From: THIJS, LAMBERTUS; KELTJENS, ROLF; ETTEMA, GERRIT J.B.
To: SYNTHON BV
Reel/Frame 014598/0708 →
Continuity (2)
Continuation In Part 1026149200 · Oct 2, 2002
Related Publication 20040068135A1 · Apr 8, 2004